FDA inspection

Jiangsu Tohope Pharmaceutical Co., Ltd.: FDA inspection ending Aug 31, 2018

FDA inspection 1066894 · Voluntary Action Indicated (VAI) · Suzhou

Key facts

Inspection ID 1066894
Firm Jiangsu Tohope Pharmaceutical Co., Ltd.
FEI number 2000019494
Address 188 Wuyishan Road, Changshu
City Suzhou
Country China
Fiscal year 2018
Inspection end date Aug 31, 2018
Classification Voluntary Action Indicated (VAI)
Project area Food Composition, Standards, Labeling and Econ
Product type Food/Cosmetics

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections